Sign In
Buy ACCD
$7.02
+0 (+0%)
At Close: Jul 07, 2025
Accolade to Acquire PlushCare
07:00am, Friday, 23'rd Apr 2021
SEATTLE, April 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced it has signed a definitive
Accolade: Interesting And Solid Healthcare Play
03:47pm, Tuesday, 06'th Apr 2021
Accolade has seen solid growth throughout the second half of 2020, now accompanied by some margin improvements as well.
Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering
04:29am, Thursday, 25'th Mar 2021
SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal amount of 0.50% convertible senior notes due 2026 (
Accolade Announces Preliminary Results for Fourth Quarter and Full Year of Fiscal Year 2021
04:03pm, Tuesday, 23'rd Mar 2021
SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) today provided preliminary unaudited financial results for the fiscal fourth quarter and year ended February 28, 2021 (fiscal
Accolade Announces Private Offering of $250 Million Convertible Notes
04:02pm, Tuesday, 23'rd Mar 2021
SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced today that it intends to offer, subject to market and other conditions, $250 million aggregate prin
Accolade to Participate in Upcoming Investor Conferences
08:00am, Tuesday, 16'th Feb 2021
SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health
Health benefits platform Accolade will pay $460M to acquire telemedicine startup 2nd.MD
05:34pm, Thursday, 14'th Jan 2021
Seattle-based Accolade announced Thursday that it will pay $460 million acquire 2nd.
Accolade agrees to buy medical-expert company for $460 million
05:23pm, Thursday, 14'th Jan 2021
Accolade Inc. said late Thursday it has agreed to buy Innovation Specialists LLC, which does business as 2nd.MD, a "leading" expert medical opinion and medical decision support company based in Housto
Accolade to Acquire 2nd.MD
04:50pm, Thursday, 14'th Jan 2021
The addition of 2nd.MD's Expert Medical Opinion services to Accolade's portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade's clinical capabilities and creates th
Healthtech firm Accolade is buying telemedicine start-up 2nd.MD for $460 million, sources say
04:35pm, Thursday, 14'th Jan 2021
Just as the digitization of finance has attracted billions in investment and a flurry of M&A, health tech has seen a surge in interest during the pandemic.
Accolade Inc.: Bullish Outlook As Its HealthTech Platform Helps Companies Save
03:14pm, Tuesday, 12'th Jan 2021
Accolade integrates workplace benefits into one platform and helps organizations save on employee healthcare costs through a virtual concierge service. The company launched its IPO in July of 2020 and
Accolade to Participate in 39th Annual J.P. Morgan Healthcare Conference
08:00am, Monday, 11'th Jan 2021
SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health
Accolade, Inc. (ACCD) CEO Rajeev Singh on Q3 2021 Results - Earnings Call Transcript
10:56pm, Thursday, 07'th Jan 2021
Accolade, Inc. (ACCD) CEO Rajeev Singh on Q3 2021 Results - Earnings Call Transcript
Accolade Announces Results for Fiscal Third Quarter 2021
04:05pm, Thursday, 07'th Jan 2021
SEATTLE, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health
Accolade to Announce Fiscal Third Quarter 2021 Financial Results
08:00am, Wednesday, 23'rd Dec 2020
SEATTLE, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health
